The role of protein kinase a regulation of the E6 PDZ-binding domain during the differentiation-dependent life cycle of human papillomavirus type 18

Journal of Virology

Volumn 87, Issue 17, 2013, Pages 9463-9472

  Delury, Craig P ^a,c   Marsh, Elizabeth K ^a   James, Claire D ^a   Boon, Siaw Shi ^b   Banks, Lawrence ^b   Knight, Gillian L ^a,d   Roberts, Sally ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b Intl Ctr Genetic Eng and Biotech   (Italy)

^c LANCASTER UNIVERSITY   (United Kingdom)

^d UNIVERSITY OF DERBY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; PDZ PROTEIN; PROTEIN E6; DNA BINDING PROTEIN; E6 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 18; ONCOPROTEIN;

ARTICLE; CELL CYCLE S PHASE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME REGULATION; GENE AMPLIFICATION; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN TISSUE; HYPERPLASIA; KERATINOCYTE; MALE; MOLECULAR RECOGNITION; NEWBORN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN MOTIF; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR PROMOTION; VIROGENESIS; VIRUS CELL INTERACTION; VIRUS GENOME; VIRUS MUTANT; WILD TYPE; AMINO ACID SEQUENCE; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CHEMISTRY; CYTOLOGY; ENZYMOLOGY; GENETICS; GROWTH, DEVELOPMENT AND AGING; HOST PATHOGEN INTERACTION; METABOLISM; PDZ DOMAIN; PHYSIOLOGY; PLASMID; SITE DIRECTED MUTAGENESIS; VIROLOGY; VIRUS REPLICATION;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 18;

AMINO ACID SEQUENCE; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DNA-BINDING PROTEINS; GENOME, VIRAL; HOST-PATHOGEN INTERACTIONS; HUMAN PAPILLOMAVIRUS 18; HUMANS; KERATINOCYTES; MUTAGENESIS, SITE-DIRECTED; ONCOGENE PROTEINS, VIRAL; PDZ DOMAINS; PLASMIDS; S PHASE; SIGNAL TRANSDUCTION; VIRUS REPLICATION;

EID: 84883292913     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01234-13     Document Type: Article

References (42)

1. Bernard HU, Burk RD, Chen Z, van Doorslaer K, Hausen H, de Villiers EM. 2010. Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology 401:70-79.
2. Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, Benbrahim-Tallaa L, Guha N, Freeman C, Galichet L, Cogliano V. 2009.A review of human carcinogens. Part B. Biological agents. Lancet Oncol. 10:321-322.
3. Kreimer AR, Clifford GM, Boyle P, Franceschi S. 2005. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol. Biomarkers Prev. 14:467-475.
4. de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, Tous S, Felix A, Bravo LE, Shin HR, Vallejos CS, de Ruiz PA, Lima MA, Guimera N, Clavero O, Alejo M, Llombart-Bosch A, Cheng-Yang C, Tatti SA, Kasamatsu E, Iljazovic E, Odida M, Prado R, Seoud M, Grce M, Usubutun A, Jain A, Suarez GA, Lombardi LE, Banjo A, Menendez C, Domingo EJ, Velasco J, Nessa A, Chichareon SC, Qiao YL, Lerma E, Garland SM, Sasagawa T, Ferrera A, Hammouda D, Mariani L, Pelayo A, Steiner I, Oliva E, Meijer CJ, Al-Jassar WF, Cruz E, Wright TC, Puras A, Llave CL, Tzardi M, Agorastos T, Garcia-Barriola V, Clavel C, Ordi J, Andujar M, Castellsague X, Sanchez GI, Nowakowski AM, Bornstein J, Munoz N, Bosch FX. 2010. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol. 11:1048-1056.
5. Hebner CM, Laimins LA. 2006. Human papillomaviruses: basic mechanisms of pathogenesis and oncogenicity. Rev. Med. Virol. 16:83-97.
6. Lee C, Laimins LA. 2004. Role of the PDZ domain-binding motif of the oncoprotein E6 in the pathogenesis of human papillomavirus type 31. J. Virol. 78:12366-12377.
7. Nicolaides L, Davy C, Raj K, Kranjec C, Banks L, Doorbar J. 2011. Stabilization of HPV16 E6 protein by PDZ proteins, and potential implications for genome maintenance. Virology 414:137-145.
8. Park RB, Androphy EJ. 2002. Genetic analysis of high-risk E6 in episomal maintenance of human papillomavirus genomes in primary human keratinocytes. J. Virol. 76:11359-11364.
9. Thomas JT, Hubert WG, Ruesch MN, Laimins LA. 1999. Human papillomavirus type 31 oncoproteins E6 and E7 are required for the maintenance of episomes during the viral life cycle in normal human keratinocytes. Proc. Natl. Acad. Sci. U. S. A. 96:8449-8454.
10. Wang HK, Duffy AA, Broker TR, Chow LT. 2009. Robust production and passaging of infectious HPV in squamous epithelium of primary human keratinocytes. Genes Dev. 23:181-194.
11. Gardiol D, Kuhne C, Glaunsinger B, Lee SS, Javier R, Banks L. 1999. Oncogenic human papillomavirus E6 proteins target the discs large tumour suppressor for proteasome-mediated degradation. Oncogene 18: 5487-5496.
12. Glaunsinger BA, Lee SS, Thomas M, Banks L, Javier R. 2000. Interactions of the PDZ-protein MAGI-1 with adenovirus E4-ORF1 and highrisk papillomavirus E6 oncoproteins. Oncogene 19:5270-5280.
13. Kiyono T, Hiraiwa A, Fujita M, Hayashi Y, Akiyama T, Ishibashi M. 1997. Binding of high-risk human papillomavirus E6 oncoproteins to the human homologue of the Drosophila discs large tumor suppressor protein. Proc. Natl. Acad. Sci. U. S. A. 94:11612-11616.
14. Nakagawa S, Huibregtse JM. 2000. Human Scribble (Vartul) is targeted for ubiquitin-mediated degradation by the high-risk papillomavirus E6 proteins and the E6AP ubiquitin-protein ligase. Mol. Cell. Biol. 20:8244-8253.
15. Thomas M, Laura R, Hepner K, Guccione E, Sawyers C, Lasky L, Banks L. 2002. Oncogenic human papillomavirus E6 proteins target the MAGI-2 and MAGI-3 proteins for degradation. Oncogene 21:5088-5096.
16. Pim D, Bergant M, Boon SS, Ganti K, Kranjec C, Massimi P, Subbaiah VK, Thomas M, Tomaic V, Banks L. 2012. Human papillomaviruses and the specificity of PDZ domain targeting. FEBS J. 279:3530-3537.
17. Kuhne C, Gardiol D, Guarnaccia C, Amenitsch H, Banks L. 2000. Differential regulation of human papillomavirus E6 by protein kinase A: conditional degradation of human discs large protein by oncogenic E6. Oncogene 19:5884-5891.
18. Zhang Y, Dasgupta J, Ma RZ, Banks L, Thomas M, Chen XS. 2007. Structures of a human papillomavirus (HPV) E6 polypeptide bound to MAGUK proteins: mechanisms of targeting tumor suppressors by a highrisk HPV oncoprotein. J. Virol. 81:3618-3626.
19. Boon SS, Banks L. 2013. High-risk human papillomavirus E6 oncoproteins interact with 14-3-3zeta in a PDZ binding motif-dependent manner. J. Virol. 87:1586-1595.
20. Ruesch MN, Laimins LA. 1998. Human papillomavirus oncoproteins alter differentiation-dependent cell cycle exit on suspension in semisolid medium. Virology 250:19-29.
21. Wilson R, Ryan GB, Knight GL, Laimins LA, Roberts S. 2007. The full-length E1^E4 protein of human papillomavirus type 18 modulates differentiation-dependent viral DNA amplification and late gene expression. Virology 362:453-460.
22. Knight GL, Pugh AG, Yates E, Bell I, Wilson R, Moody CA, Laimins LA, Roberts S. 2011. A cyclin-binding motif in human papillomavirus type 18 (HPV18) E1^E4 is necessary for association with CDK-cyclin complexes and G2/M cell cycle arrest of keratinocytes, but is not required for differentiation-dependent viral genome amplification or L1 capsid protein expression. Virology 412:196-210.
23. Watson RA, Rollason TP, Reynolds GM, Murray PG, Banks L, Roberts S. 2002. Changes in expression of the human homologue of the Drosophila discs large tumour suppressor protein in high-grade premalignant cervical neoplasias. Carcinogenesis 23:1791-1796.
24. Pim D, Tomaic V, Banks L. 2009. The human papillomavirus (HPV) E6* proteins from high-risk, mucosal HPVs can direct degradation of cellular proteins in the absence of full-length E6 protein. J. Virol. 83:9863-9874.
25. Thomas M, Massimi P, Navarro C, Borg JP, Banks L. 2005. The hScrib/Dlg apico-basal control complex is differentially targeted by HPV-16 and HPV-18 E6 proteins. Oncogene 24:6222-6230.
26. Thomas M, Dasgupta J, Zhang Y, Chen X, Banks L. 2008. Analysis of specificity determinants in the interactions of different HPV E6 proteins with their PDZ domain-containing substrates. Virology 376:371-378.
27. Collins SI, Constandinou-Williams C, Wen K, Young LS, Roberts S, Murray PG, Woodman CB. 2009. Disruption of the E2 gene is a common and early event in the natural history of cervical human papillomavirus infection: a longitudinal cohort study. Cancer Res. 69:3828-3832.
28. Nakahara T, Peh WL, Doorbar J, Lee D, Lambert PF. 2005. Human papillomavirus type 16 E1^E4 contributes to multiple facets of the papillomavirus life cycle. J. Virol. 79:13150-13165.
29. Wilson R, Fehrmann F, Laimins LA. 2005. Role of the E1^E4 protein in the differentiation-dependent life cycle of human papillomavirus type 31. J. Virol. 79:6732-6740.
30. Cheng S, Schmidt-Grimminger DC, Murant T, Broker TR, Chow LT. 1995. Differentiation-dependent up-regulation of the human papillomavirus E7 gene reactivates cellular DNA replication in suprabasal differentiated keratinocytes. Genes Dev. 9:2335-2349.
31. Shai A, Brake T, Somoza C, Lambert PF. 2007. The human papillomavirus E6 oncogene dysregulates the cell cycle and contributes to cervical carcinogenesis through two independent activities. Cancer Res. 67:1626-1635.
32. Nguyen ML, Nguyen MM, Lee D, Griep AE, Lambert PF. 2003. The PDZ ligand domain of the human papillomavirus type 16 E6 protein is required for E6's induction of epithelial hyperplasia in vivo. J. Virol. 77: 6957-6964.
33. Nguyen MM, Nguyen ML, Caruana G, Bernstein A, Lambert PF, Griep AE. 2003. Requirement of PDZ-containing proteins for cell cycle regulation and differentiation in the mouse lens epithelium. Mol. Cell. Biol. 23:8970-8981.
34. Bilder D, Li M, Perrimon N. 2000. Cooperative regulation of cell polarity and growth by Drosophila tumor suppressors. Science 289:113-116.
35. Woods DF, Hough C, Peel D, Callaini G, Bryant PJ. 1996. Dlg protein is required for junction structure, cell polarity, and proliferation control in Drosophila epithelia. J. Cell Biol. 134:1469-1482.
36. Kho EY, Wang HK, Banerjee NS, Broker TR, Chow LT. 2013. HPV-18 E6 mutants reveal p53 modulation of viral DNA amplification in organotypic cultures. Proc. Natl. Acad. Sci. U. S. A. 110:7542-7549.
37. Banks L, Pim D, Thomas M. 2012. Human tumour viruses and the deregulation of cell polarity in cancer. Nat. Rev. Cancer 12:877-886.
38. Roberts S, Delury C, Marsh E. 2012. The PDZ protein discs-large (DLG): the 'Jekyll and Hyde' of the epithelial polarity proteins. FEBS J. 279:3549-3558.
39. Lee HJ, Zheng JJ. 2010. PDZ domains and their binding partners: structure, specificity, and modification. Cell Commun. Signal. 8:8. doi:10.1186 /1478-811X-8-8.
40. Simonson SJ, Difilippantonio MJ, Lambert PF. 2005. Two distinct activities contribute to human papillomavirus 16 E6's oncogenic potential. Cancer Res. 65:8266-8273.
41. Spanos WC, Hoover A, Harris GF, Wu S, Strand GL, Anderson ME, Klingelhutz AJ, Hendriks W, Bossler AD, Lee JH. 2008. The PDZ binding motif of human papillomavirus type 16 E6 induces PTPN13 loss, which allows anchorage-independent growth and synergizes with Ras for invasive growth. J. Virol. 82:2493-2500.
42. Watson RA, Thomas M, Banks L, Roberts S. 2003. Activity of the human papillomavirus E6 PDZ-binding motif correlates with an enhanced morphological transformation of immortalized human keratinocytes. J. Cell Sci. 116:4925-4934. Delury et al.